title: Activated macrophages use different cytolytic mechanisms to lyse a virally infected or a tumor target.
abstract: Murine bone-marrow-culture-derived-macrophages can be differentially activated to lyse either vesicular stomatitis virus infected BALB/c3T3 cells or the tumor target P815. Macrophages were activated in a manner so that they could lyse both targets. The ability of this activated population to lyse either target type was differentially inhibited by varying the assay conditions. The lysis of P815 targets was more sensitive to inhibition by the proteinase inhibitor N-p-tosyl-L-lysine chloromethyl ketone than was the lysis of virally infected cells. On the other hand, reduction of the concentration of glucose in the assay medium, which inhibits the production of oxygen metabolites by the hexose monophosphate shunt, or the addition of anti-tumor necrosis factor (anti-TNF) serum were able to decrease the lysis of virally infected targets but not P815 targets. Thus, the observed differences in the lysis of these two targets were due to both the activation state of the macrophages and the differential susceptibility of the targets to different effector mechanisms.
authors.affiliation: Department of Microbiology, University of Alabama, Tuscaloosa 35487-0334.
authors.forename: P A
authors.initials: PA
authors.lastname: LeBlanc
authors.forename: L S
authors.initials: LS
authors.lastname: Heath
authors.forename: H D
authors.initials: HD
authors.lastname: Um
mesh_terms: D000818:Animals; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D005347:Fibroblasts / Q000187:drug effects / Q000382:microbiology / Q000502:physiology*; D005947:Glucose / Q000378:metabolism; D008262:Macrophage Activation / Q000502:physiology*; D008264:Macrophages / Q000502:physiology*; D012515:Mast-Cell Sarcoma / Q000382:microbiology / Q000473:pathology / Q000503:physiopathology*; D051379:Mice; D008807:Mice, Inbred BALB C; D011480:Protease Inhibitors / Q000494:pharmacology; D012513:Sarcoma, Experimental / Q000382:microbiology / Q000473:pathology / Q000503:physiopathology*; D013280:Stomatitis / Q000473:pathology / Q000503:physiopathology; D014107:Tosyllysine Chloromethyl Ketone / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000382:microbiology / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology; D014721:Vesicular stomatitis Indiana virus / Q000302:isolation & purification
chemical_list: D011480:Protease Inhibitors; D014409:Tumor Necrosis Factor-alpha; D014107:Tosyllysine Chloromethyl Ketone; D005947:Glucose